Generic Drug Co. Can Continue Arbitration Against Ranbaxy
Law360 (March 13, 2018, 7:13 PM EDT) — A Texas appellate court on Monday allowed a generic drug developer to move forward in arbitration with claims it had been fraudulently induced to assign patent rights to Ranbaxy Inc., reversing a trial court’s determination that the arbitration panel had missed a …